Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ellomay Capital (ELLO) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Ellomay Capital (ELLO) over the last 11 years, with Q3 2025 value amounting to -$25.8 million.

  • Ellomay Capital's Capital Expenditures rose 2272.73% to -$25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$46.7 million, marking a year-over-year decrease of 410.7%. This contributed to the annual value of $75.9 million for FY2024, which is 12909163.95% up from last year.
  • Per Ellomay Capital's latest filing, its Capital Expenditures stood at -$25.8 million for Q3 2025, which was up 2272.73% from -$20.8 million recorded in Q2 2025.
  • Ellomay Capital's Capital Expenditures' 5-year high stood at -$9750.0 during Q1 2024, with a 5-year trough of -$47.0 million in Q2 2021.
  • For the 5-year period, Ellomay Capital's Capital Expenditures averaged around -$13.8 million, with its median value being -$11.4 million (2024).
  • The largest annual percentage gain for Ellomay Capital's Capital Expenditures in the last 5 years was 9996.18% (2021), contrasted with its biggest fall of 6634596.0% (2021).
  • Ellomay Capital's Capital Expenditures (Quarter) stood at -$11581.0 in 2021, then rose by 12.11% to -$10178.0 in 2022, then dropped by 4.84% to -$10671.0 in 2023, then plummeted by 123.33% to -$23832.0 in 2024, then tumbled by 108338.79% to -$25.8 million in 2025.
  • Its last three reported values are -$25.8 million in Q3 2025, -$20.8 million for Q2 2025, and -$20066.0 during Q1 2025.